U.S. Physical Therapy, Inc. (NYSE:USPH) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages

Key Points

• U.S. Physical Therapy has a “Moderate Buy” consensus rating from seven analysts: four buys, one strong buy and two holds. The average 12-month price target is $98.25, above the reported share price of $86.52.
• The company’s latest quarterly results were mixed: revenue rose 8.5% year over year to $214.06 million and exceeded estimates, but earnings per share of $0.75 fell short of the $0.81 consensus.
• U.S. Physical Therapy recently paid a quarterly dividend of $0.46 per share, equivalent to an annualized $1.84 dividend and a 2.1% yield.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $98.25.

USPH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, September 11th. Citigroup reaffirmed a "market outperform" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Weiss Ratings reiterated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an "outperform" rating in a report on Monday, August 10th. Finally, Citizens Jmp restated a "market outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock opened at $86.52 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a fifty day moving average price of $79.40 and a two-hundred day moving average price of $73.18. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $93.50. The firm has a market capitalization of $1.29 billion, a P/E ratio of 508.96, a P/E/G ratio of 2.16 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The firm's revenue was up 8.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.81 earnings per share. As a group, analysts anticipate that U.S. Physical Therapy will post 2.89 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 21st were given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Friday, August 21st. U.S. Physical Therapy's dividend payout ratio is presently 1,082.35%.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds and other institutional investors have recently modified their holdings of USPH. Integrated Wealth Concepts LLC bought a new position in U.S. Physical Therapy in the 2nd quarter worth approximately $33,000. Baird Financial Group Inc. boosted its position in U.S. Physical Therapy by 10.2% in the 2nd quarter. Baird Financial Group Inc. now owns 6,629 shares of the company's stock valued at $455,000 after buying an additional 613 shares during the last quarter. HighTower Advisors LLC bought a new position in U.S. Physical Therapy in the 2nd quarter valued at $202,000. Penn Capital Management Company LLC acquired a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at $648,000. Finally, Corient Private Wealth LP acquired a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at $212,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc is a healthcare company that operates outpatient physical therapy clinics and manages physical therapy practices throughout the United States. Its clinics provide rehabilitation services for patients recovering from injuries, surgeries, illnesses and chronic conditions, with treatment commonly focused on restoring mobility, strength and function.

The company operates both physical therapy facilities and physical therapy management partnerships. In addition to traditional outpatient rehabilitation, its services include sports medicine, workers' compensation care and related programs designed to help employers prevent and manage workplace injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.